Published online Feb 16, 2026. doi: 10.4253/wjge.v18.i2.114771
Revised: October 30, 2025
Accepted: December 1, 2025
Published online: February 16, 2026
Processing time: 129 Days and 14.4 Hours
Endoscopic transpapillary biliary drainage is currently recommended as the gold standard treatment modality for distal malignant biliary obstruction (DMBO) with endoscopic ultrasound (EUS)-guided biliary drainage being advocated in cases of endoscopic retrograde cholangiopancreatography failure. EUS-guided gallbladder drainage (GBD) has recently been proposed as a promising “rescue” and first-line alternative tool for managing DMBO. Indeed, high rates of both technical and clinical success along with a favorable safety profile have been reported. However, evidence regarding the capability of EUS-GBD to normalize total bilirubin in patients with DMBO is still lacking. Notably, bilirubin normalization is regarded as mandatory before starting chemotherapy, thus representing a crucial outcome of any biliary drainage method for DMBO. Our study aimed to summarize and discuss the cur
Core Tip: Endoscopic ultrasound (EUS)-guided gallbladder drainage (GBD) has recently been proposed as a promising “rescue” and first-line option for managing distal malignant biliary obstruction (DMBO). Indeed, high rates of both technical and clinical success along with low adverse events rates have been reported. However, evidence concerning the effectiveness of EUS-GBD for bilirubin normalization in DMBO is currently still lacking. Our study aimed to review the current evidence about the efficacy of EUS-GBD for bilirubin normalization in patients with DMBO.
